| __timestamp | BioMarin Pharmaceutical Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 1802274 |
| Thursday, January 1, 2015 | 402271000 | 2512761 |
| Friday, January 1, 2016 | 476593000 | 2894488 |
| Sunday, January 1, 2017 | 554336000 | 8096274 |
| Monday, January 1, 2018 | 604353000 | 7985229 |
| Tuesday, January 1, 2019 | 680924000 | 8994597 |
| Wednesday, January 1, 2020 | 737669000 | 29772000 |
| Friday, January 1, 2021 | 759375000 | 33907000 |
| Saturday, January 1, 2022 | 854009000 | 26579000 |
| Sunday, January 1, 2023 | 937300000 | 49868547 |
| Monday, January 1, 2024 | 1009025000 |
Data in motion
In the competitive world of biopharmaceuticals, operational efficiency is key. BioMarin Pharmaceutical Inc. and Verona Pharma plc, two prominent players, showcase contrasting strategies in managing Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, BioMarin's SG&A expenses surged by over 200%, peaking at approximately $937 million in 2023. This reflects their aggressive expansion and investment in operational infrastructure. In contrast, Verona Pharma's SG&A expenses, though significantly lower, increased by a staggering 2,600% during the same period, reaching nearly $50 million. This sharp rise indicates a strategic shift towards scaling operations and market presence. The data highlights the diverse approaches these companies take in navigating the complex landscape of the pharmaceutical industry, balancing growth with cost management.
Amgen Inc. vs Verona Pharma plc: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Verona Pharma plc
Who Optimizes SG&A Costs Better? Biogen Inc. or Verona Pharma plc
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and BioMarin Pharmaceutical Inc.
Comparing SG&A Expenses: Insmed Incorporated vs BioMarin Pharmaceutical Inc. Trends and Insights
BioMarin Pharmaceutical Inc. and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Xencor, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Opthea Limited or Verona Pharma plc
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Verona Pharma plc vs Merus N.V.
Who Optimizes SG&A Costs Better? Verona Pharma plc or Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Verona Pharma plc vs Wave Life Sciences Ltd. Trends and Insights